Clinical trial • Cardiology
Clinical trial in Atrial fibrillation|Coronary artery disease
Clinical trial for Atrial fibrillation|Coronary artery disease. 136 participants.
Overview
- Trial Therapeutic Area
- Cardiology
- Trial Disease
- Atrial fibrillation|Coronary artery disease
Key dates
- Initial CTIS Submission Date
- 28-08-2025
- First CTIS Authorization Date
- 22-10-2025
Trial design
Clinical trial across 1 site in Hungary.
- Target Sample Size
- 136
Eligibility
Recruits 136 Vulnerable population not selected; isVulnerablePopulationSelected=false and no special consent or assent procedures are described in the available record..
- Vulnerable Population
- Vulnerable population not selected; isVulnerablePopulationSelected=false and no special consent or assent procedures are described in the available record.
Recruitment
- Planned Sample Size
- 136
- Recruitment Window Months
- 12
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 136
Hungary
- Earliest CTIS Part Ii Submission Date
- 02-10-2025
- Latest Decision Or Authorization Date
- 22-10-2025
- Processing Time Days
- 20
- Number Of Sites
- 1
- Number Of Participants
- 136
Sites
- Site Name
- Semmelweis University - Varosmajor Utca 68, Kerulet
- Department Name
- Department of Cardiology
- Principal Investigator Name
- Drobni Zsófia Dóra
- Principal Investigator Email
- drobni.zsofia@semmelweis.hu
- Contact Person Name
- Drobni Zsófia Dóra
- Contact Person Email
- drobni.zsofia@semmelweis.hu
Sponsor
Primary sponsor
- Full Name
- Semmelweis University
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Hungary
Related trials
Other published trials that may interest you.
- METHYLPREDNISOLONE for Fulminant myocarditis
- PELACARSEN for Cardiovascular disease | Arteriosclerotic cardiovascular disease
- clopidogrel for Acute coronary syndrome | Cardiovascular diseases
- APIXABAN for Venous thromboembolism
- SOTAGLIFLOZIN for Obstructive hypertrophic cardiomyopathy | Non-obstructive hypertrophic cardiomyopathy